علاج داء النشواني القلبي بالترانسثيريتين (ATTR-CM)

References

DOI: 10.1093/eurheartj/ehad194

• Transthyretin stabilization and reduction of its production are the basis of TTR cardiac amyloidosis treatment.
• Tafamidis reduced all-cause mortality and cardiovascular hospitalizations in ATTR, with the largest effect achieved in patients at NYHA functional class I and II.